Paper30302012
Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H.
Patutina OA and 6 others. Sci Rep, 2018. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H. Papers, record 30302012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30302012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma, Experimental | Major topic |
| MicroRNAs | Major topic |
| Ribonuclease H | Major topic |
| Animals | |
| Carcinogenesis | |
| Cell Line, Tumor | |
| Gene Silencing | |
| Humans | |
| Mice | |
| Oligodeoxyribonucleotides | |
| Peptides | |
| Pyrimidines | |
| Substrate Specificity |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29280958 | Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/29280958 | PubMed |
| 2 | 8392706 | Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity. | Nucleic Acids Res | 1993 | https://conductscience.org/library/papers/8392706 | PubMed |
| 3 | 17400817 | Double-stranded regions are essential design components of potent inhibitors of RISC function. | RNA | 2007 | https://conductscience.org/library/papers/17400817 | PubMed |
| 4 | 25101673 | Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy? | Cell Death Dis | 2014 | https://conductscience.org/library/papers/25101673 | PubMed |
| 5 | 5433534 | Peptide synthesis via the oxidation-reduction condensation by the use of 2,2'-dipyridyldisulfide as a oxidant. | Tetrahedron Lett | 1970 | https://conductscience.org/library/papers/5433534 | PubMed |
| 6 | 16557279 | Oncomirs - microRNAs with a role in cancer. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16557279 | PubMed |
| 7 | 409999 | Mapping adenines, guanines, and pyrimidines in RNA. | Nucleic Acids Res | 1977 | https://conductscience.org/library/papers/409999 | PubMed |
| 8 | 25955796 | Peptidyl-oligonucleotide conjugates demonstrate efficient cleavage of RNA in a sequence-specific manner. | Bioconjug Chem | 2015 | https://conductscience.org/library/papers/25955796 | PubMed |
| 9 | 14744438 | MicroRNAs: genomics, biogenesis, mechanism, and function. | Cell | 2004 | https://conductscience.org/library/papers/14744438 | PubMed |
| 10 | 29415514 | Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/29415514 | PubMed |
| 11 | 17931426 | Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. | Plant Methods | 2007 | https://conductscience.org/library/papers/17931426 | PubMed |
| 12 | 24989082 | SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1. | Cancer Sci | 2014 | https://conductscience.org/library/papers/24989082 | PubMed |
| 13 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 14 | 1508675 | Extraordinarily stable mini-hairpins: electrophoretical and thermal properties of the various sequence variants of d(GCGAAAGC) and their effect on DNA sequencing. | Nucleic Acids Res | 1992 | https://conductscience.org/library/papers/1508675 | PubMed |
| 15 | 17612493 | MicroRNA targeting specificity in mammals: determinants beyond seed pairing. | Mol Cell | 2007 | https://conductscience.org/library/papers/17612493 | PubMed |
| 16 | 8963230 | [RNA hydrolysis catalyzed by imidazole as a reaction for studying the secondary structure of RNA and complexes of RNA with oligonucleotides]. | Dokl Akad Nauk | 1996 | https://conductscience.org/library/papers/8963230 | PubMed |
| 17 | 220499 | Use of in vitro 32P labeling in the sequence analysis of nonradioactive tRNAs. | Methods Enzymol | 1979 | https://conductscience.org/library/papers/220499 | PubMed |
| 18 | 11896390 | Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. | Nat Genet | 2002 | https://conductscience.org/library/papers/11896390 | PubMed |
| 19 | 10037819 | Oligonucleotide-europium complex conjugate designed to cleave the 5' cap structure of the ICAM-1 transcript potentiates antisense activity in cells. | Nucleic Acids Res | 1999 | https://conductscience.org/library/papers/10037819 | PubMed |
| 20 | 20424893 | A direct comparison of anti-microRNA oligonucleotide potency. | Pharm Res | 2010 | https://conductscience.org/library/papers/20424893 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353165 | Panel-Wide Screening of Tumour Cells of Diverse Histogenesis for Responsiveness to Silencing of miR-21, miR-17, and miR-155 by Mesyl Phosphoramidate Antisense Oligonucleotides. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353165 | PubMed |
| 41556568 | Mini-Hairpin DNA: Extraordinarily Stable Structure and Its Applications. | Chemistry | 2026 | https://conductscience.org/library/papers/41556568 | PubMed |
| 41373892 | Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373892 | PubMed |
| 40626302 | Opening new frontiers with catalytic nucleic acids in miRNA inhibition. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40626302 | PubMed |
| 38994018 | Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death. | Theranostics | 2024 | https://conductscience.org/library/papers/38994018 | PubMed |
| 37222810 | Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37222810 | PubMed |
| 36153384 | Targeting non-coding RNA family members with artificial endonuclease XNAzymes. | Commun Biol | 2022 | https://conductscience.org/library/papers/36153384 | PubMed |
| 36139555 | Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36139555 | PubMed |
| 35743015 | Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35743015 | PubMed |
| 34976439 | Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/34976439 | PubMed |
| 33808835 | Site-Selective Artificial Ribonucleases: Renaissance of Oligonucleotide Conjugates for Irreversible Cleavage of RNA Sequences. | Molecules | 2021 | https://conductscience.org/library/papers/33808835 | PubMed |
| 33409253 | Sry-related High Mobility Group Box 17 Functions as a Tumor Suppressor by Antagonizing the Wingless-related Integration Site Pathway. | J Cancer Prev | 2020 | https://conductscience.org/library/papers/33409253 | PubMed |
| 33288723 | Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/33288723 | PubMed |
| 32466298 | Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance. | Molecules | 2020 | https://conductscience.org/library/papers/32466298 | PubMed |
| 32316292 | A Trisbenzimidazole Phosphoramidite Building Block Enables High-Yielding Syntheses of RNA-Cleaving Oligonucleotide Conjugates. | Molecules | 2020 | https://conductscience.org/library/papers/32316292 | PubMed |
| 31456683 | Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31456683 | PubMed |
| 31156429 | Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31156429 | PubMed |
| 30622178 | Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/30622178 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30302012
GET https://conductscience.org/api/papers/v1/30302012/references?page=2